Immediate preoperative hyperglycemia correlates with complications in non-cardiac surgical cases.
DM control: glycosylated Hgb
Hyperglycemia: complications
Outpatient surgery contraindications
Perioperative insulin: effects
Perioperative risk of MI
Postoperative cardiac event: risk factors
Journal
Journal of clinical anesthesia
ISSN: 1873-4529
Titre abrégé: J Clin Anesth
Pays: United States
ID NLM: 8812166
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
11
02
2021
revised:
07
05
2021
accepted:
11
05
2021
pubmed:
20
6
2021
medline:
24
12
2021
entrez:
19
6
2021
Statut:
ppublish
Résumé
Assess for a relationship between immediate preoperative glucose concentrations and postoperative complications. Retrospective cohort study. Single large, tertiary care academic medical center. A five-year registry of all patients at our hospital who had a glucose concentration (plasma, serum, or venous/capillary/arterial whole blood) measured up to 6 h prior to a non-emergent surgery. The glucose registry was cross-referenced with a database from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). We applied an outcomes review to the subset of patients for whom we had data from both registries (n = 1774). Preoperative glucose concentration in the full population as well as the subgroups of patients with or without diabetes were correlated with adverse postsurgical outcomes using 1) univariable analysis and 2) full multivariable analysis correcting for 27 clinical factors available from the ACS NSQIP database. Logistic regression analysis was performed using glucose level either as a continuous variable or as a categorical variable according to the following classifications: mild (≥140 mg/dL; ≥7.8 mmol/L), moderate (≥180 mg/dL; ≥10 mmol/L), or severe (≥250 mg/dL; ≥13.9 mmol/L) hyperglycemia. A third analysis was performed correcting for 7 clinically important factors (age, BMI, predicted duration of procedure, sex, CKD stage, hypoalbuminemia, and diabetic status) identified by anesthesiologists and surgeons as immediately available and important for decision making. Univariable analysis of all patients and the subgroups of patients without diabetes or with diabetes showed that immediate preoperative mild or moderate hyperglycemia correlates with postoperative complications. Statistical significance was lost in most groups using full multivariable analysis, but not when correcting for the 7 factors available immediately preoperatively. However, for all patients with diabetes, moderate hyperglycemia (≥180 mg/dL; ≥10 mmol/L) continued to significantly correlate with complications even in the full multivariable analysis [odds ratio (OR) 1.79; 95% Confidence Intervals (CI) 1.10, 2.92], and with readmission/reoperation within 30 days [OR 1.93; 95% CI 1.18, 3.13]. Preoperative hyperglycemia within 6 h of surgery is a marker of adverse postoperative outcomes. Among patients with diabetes in our study, a preoperative glucose level ≥ 180 mg/dL (≥10 mmol/L) independently correlates with risk of postoperative complications and readmission/reoperation. These results should encourage future work to determine whether addressing immediate preoperative hyperglycemia can improve complication rates, or simply serves as a marker of higher risk.
Identifiants
pubmed: 34147016
pii: S0952-8180(21)00214-2
doi: 10.1016/j.jclinane.2021.110375
pmc: PMC8627687
mid: NIHMS1757059
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110375Subventions
Organisme : BLRD VA
ID : I01 BX004468
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK054759
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Références
Br J Anaesth. 2014 Jan;112(1):79-88
pubmed: 24009267
Am Surg. 2017 Oct 1;83(10):1108-1111
pubmed: 29391105
J Surg Res. 2014 Jan;186(1):371-8
pubmed: 24148355
N Engl J Med. 2001 Nov 8;345(19):1359-67
pubmed: 11794168
Diabetes Care. 2010 Aug;33(8):1783-8
pubmed: 20435798
Diabet Med. 2012 Apr;29(4):420-33
pubmed: 22288687
Crit Care Med. 2018 Jun;46(6):935-942
pubmed: 29509570
N Engl J Med. 2009 Mar 26;360(13):1283-97
pubmed: 19318384
Ann Thorac Surg. 2009 Feb;87(2):663-9
pubmed: 19161815
Anesth Analg. 2010 Dec;111(6):1378-87
pubmed: 20889933
Diabetes Care. 2021 Jan;44(Suppl 1):S211-S220
pubmed: 33298426
Crit Care Med. 2012 Dec;40(12):3251-76
pubmed: 23164767
Eur J Endocrinol. 2007 Jan;156(1):137-42
pubmed: 17218737
Diabetes Care. 2015 Sep;38(9):1665-72
pubmed: 26180108
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
J Thorac Cardiovasc Surg. 2003 May;125(5):1007-21
pubmed: 12771873
Ann Surg. 2018 May;267(5):858-862
pubmed: 28549013
Intensive Care Med. 2016 Sep;42(9):1475-7
pubmed: 27161084
Ann Intern Med. 2007 Feb 20;146(4):233-43
pubmed: 17310047
JAMA. 2019 Jan 29;321(4):399-400
pubmed: 30615031
Diabetes Care. 2018 Apr;41(4):782-788
pubmed: 29440113
Int J Colorectal Dis. 2017 Feb;32(2):209-214
pubmed: 27864588
J Arthroplasty. 2010 Jan;25(1):64-70
pubmed: 19056217
BMC Endocr Disord. 2018 Jun 22;18(1):42
pubmed: 29929558
Ann Surg. 2013 Jan;257(1):8-14
pubmed: 23235393
JAMA Surg. 2017 Aug 1;152(8):784-791
pubmed: 28467526
Curr Diab Rep. 2019 Nov 20;19(11):134
pubmed: 31749027